Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Net Income (2023 - 2025)

Historic Net Income for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to -$7.6 million.

  • Mangoceuticals' Net Income fell 28099.71% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.8 million, marking a year-over-year decrease of 11253.74%. This contributed to the annual value of -$8.7 million for FY2024, which is 548.38% up from last year.
  • Latest data reveals that Mangoceuticals reported Net Income of -$7.6 million as of Q3 2025, which was down 28099.71% from -$5.4 million recorded in Q2 2025.
  • In the past 5 years, Mangoceuticals' Net Income registered a high of -$1.8 million during Q3 2023, and its lowest value of -$7.6 million during Q3 2025.
  • For the 3-year period, Mangoceuticals' Net Income averaged around -$3.3 million, with its median value being -$2.4 million (2024).
  • Its Net Income has fluctuated over the past 5 years, first soared by 2412.15% in 2024, then plummeted by 28099.71% in 2025.
  • Over the past 3 years, Mangoceuticals' Net Income (Quarter) stood at -$2.6 million in 2023, then grew by 24.12% to -$1.9 million in 2024, then crashed by 290.99% to -$7.6 million in 2025.
  • Its Net Income stands at -$7.6 million for Q3 2025, versus -$5.4 million for Q2 2025 and -$4.8 million for Q1 2025.